ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Episode 5: BioTalk: Emerging technologies in stem cell biology"
Episode Synopsis
For this 5th episode of Bohemian Biology I uploaded one of the podcasts I produced for BioTechniques. It was originally published on Biotechniques.com June 25 2009 Run Time: 32:48
Although the ban on funding embryonic stem cells was recently lifted by President Barack Obama, the controversy over this research still remains.
New types of pluripotent stem cells have recently emerged as alternatives to embryonic stem cells. These include induced pluripotent stem cells (IPS cells) and parthenogenic stem cells.
In this episode of BioTalk, Kent Vrana (1:25) , Ph.D., chair of the department of Pharmacology at Penn State University College of Medicine, and Ken Aldrich (21:55), CEO of International Stem Cell Corporation, discuss the current state of stem cell research.
Although the ban on funding embryonic stem cells was recently lifted by President Barack Obama, the controversy over this research still remains.
New types of pluripotent stem cells have recently emerged as alternatives to embryonic stem cells. These include induced pluripotent stem cells (IPS cells) and parthenogenic stem cells.
In this episode of BioTalk, Kent Vrana (1:25) , Ph.D., chair of the department of Pharmacology at Penn State University College of Medicine, and Ken Aldrich (21:55), CEO of International Stem Cell Corporation, discuss the current state of stem cell research.
More episodes of the podcast Bohemian Biology
Episode 4: NYC Cricket Crawl
28/09/2009
Episode 2: Bushwick is Beautiful
25/08/2009
In God we trust